Norvatis
[Letter] Joint Letter of Korean NGOs to the Indian Embassy in Seoul
요약문:
On behalf of the 27 Korean NGOs, Trade Unions, I am writing to express our concerns regarding the legal proceedings that Norvatis initiated in India in May 2006, challenging the rejection of its patent application for imatinib mesylate (Gleevec/Glivec) as well as questioning the compliance of the Indian Patents Act with the World Trade Organization's Agreement on Trade-Related Aspects of Intellectual Property Rights(TRIPS).
Jan 29, 2007
N. Parthasarathi
Ambassador
Indian Embassy in Seoul
37-3, Hannam-Dong Yongsan-ku,
Seoul, South Korea
Re : The Norvatis' legal action in India on the Patent Law
Dear Ambassador N. Parthasarathi
발표일자:
2007/01/29
[Letter] Joint Letter of Korean NGOs to the Indian Embassy in Seoul
Jan 29, 2007
N. Parthasarathi
Ambassador
Indian Embassy in Seoul
37-3, Hannam-Dong Yongsan-ku,
Seoul, South Korea
Re : The Norvatis' legal action in India on the Patent Law
Dear Ambassador N. Parthasarathi
발표일자:
2007/01/29
[Letter] Joint Letter of Korean NGOs to the Norvatis
Jan 29, 2007
Daniel Vasella, MD
CEO, Norvatis
Postfach CH-4002,
Basel, Switzerland
Re : Norvatis' legal action in India on the Patent Law
Dear Sir
발표일자:
2007/01/29